| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study
|
Garon, Edward B.
|
|
|
25 |
3 |
p. 266-273.e5
|
artikel
|
| 2 |
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
|
Riudavets, Mariona
|
|
|
25 |
3 |
p. 233-243.e8
|
artikel
|
| 3 |
Brief Report: Evaluating the Impact of Perioperative Immune Checkpoint Inhibitor in the Treatment of Patients with Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
|
Ponvilawan, Ben
|
|
|
25 |
3 |
p. 254-261
|
artikel
|
| 4 |
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
|
Marmarelis, Melina E.
|
|
|
25 |
3 |
p. 262-265.e2
|
artikel
|
| 5 |
Brief Report: Nonmalignant Surgical Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules
|
Till, Brian M.
|
|
|
25 |
3 |
p. e129-e132.e4
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
25 |
3 |
p. A1
|
artikel
|
| 7 |
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non–Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment Comparison
|
Ou, Sai-Hong Ignatius
|
|
|
25 |
3 |
p. e145-e152.e3
|
artikel
|
| 8 |
ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature
|
Zhang, Wusheng
|
|
|
25 |
3 |
p. 215-224.e3
|
artikel
|
| 9 |
Lung Cancer Survival Trends in the Veterans Health Administration
|
Moghanaki, Drew
|
|
|
25 |
3 |
p. 225-232
|
artikel
|
| 10 |
Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges
|
D'Aiello, Angelica
|
|
|
25 |
3 |
p. 197-214
|
artikel
|
| 11 |
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial
|
Matsubara, Taichi
|
|
|
25 |
3 |
p. 280-283
|
artikel
|
| 12 |
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
|
Barsouk, Adam
|
|
|
25 |
3 |
p. e161-e171
|
artikel
|
| 13 |
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non–small-cell Lung Cancer
|
Mathiot, Laurent
|
|
|
25 |
3 |
p. 244-253.e2
|
artikel
|
| 14 |
So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer
|
Detterbeck, Frank
|
|
|
25 |
3 |
p. e113-e123
|
artikel
|
| 15 |
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations
|
Rodriguez-Abreu, Delvys
|
|
|
25 |
3 |
p. 274-279
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
25 |
3 |
p. A3-A6
|
artikel
|
| 17 |
The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non–Small-Cell Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study
|
Cao, Jinlin
|
|
|
25 |
3 |
p. e153-e160
|
artikel
|
| 18 |
To Crush or Not to Crush: Administering Dabrafenib and Trametinib Through a Nasogastric Tube in a Critically Ill Patient With Nonsmall Cell Lung Cancer – A Case Report and Review of Literature of Targeted Therapies Given Through Enteral Feeding Tubes
|
Jang, Charley
|
|
|
25 |
3 |
p. e124-e128
|
artikel
|
| 19 |
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network
|
Pilon, Yohann
|
|
|
25 |
3 |
p. e133-e144.e4
|
artikel
|
Tijdschrift beschrijving